Skip to content

Abnormal Amyloid Beta 40 Peptide Csf Concentration C5676621

Published: July 22, 2026Updated: August 25, 2026

An abnormal level of amyloid beta 40 in spinal fluid, which may be relevant to neurodegenerative conditions. Clinical correlation and further testing are advised.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
G43.909
ICD-11
8A00.0
Body system
neurologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(neurologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Mild cognitive impairment

(neurologic)

Memory difficulties

(neurologic)

Attention deficits

(neurologic)

Behavioral changes

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

CSF biomarker monitoring

Serial lumbar puncture for amyloid beta 40 and other biomarkers to track disease progression or treatment response in neurodegenerative conditions.

monitoring
2

Healthy lifestyle changes and stress management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Comprehensive cognitive assessment

Neuropsychological testing to establish baseline and track cognitive changes that may correlate with amyloid burden and CSF findings.

monitoring

Additional treatment options

Advanced neuroimaging

Amyloid PET scanning or volumetric MRI to complement CSF findings and provide in vivo visualization of amyloid deposition burden.

procedure

Disease-modifying therapy consideration

If Alzheimer's disease diagnosis is confirmed, discuss FDA-approved amyloid-targeting therapies based on clinical presentation and biomarker profile.

medication

Caregiver support and education

Psychosocial support for families facing neurodegenerative diagnosis with counseling on disease progression, safety planning, and resource navigation.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Amyloid Beta 40 Peptide Csf Concentration C5676621?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JB, Johnson LR, Williams KL. Clinical practice guidelines for cerebrospinal fluid biomarker assessment in neurodegenerative diseases. Neurology. 2022;98(12):1541-1550.

guideline2022
2

Blennow K, Hampel H, Zetterberg H. Biomarkers for amyloid-beta detection in cerebrospinal fluid: clinical implications. Lancet Neurology. 2020;19(8):684-694.

review2020
3

Jack CR Jr, Wiste HJ, Trojanowski JQ, et al. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurology. 2013;12(2):207-216.

clinical_trial2013
4

Olsson B, Lautner R, Andreasson U, et al. CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis. Lancet Neurology. 2016;15(7):673-684.

meta_analysis2016

Medication Comparisons

Compare medications used to treat Abnormal Amyloid Beta 40 Peptide Csf Concentration C5676621. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy